Dr Konstantinos Kamposioras : Medical oncology

Home
Dr Konstantinos Kamposioras

Bupa Platinum consultant
Fee assured
Awaiting verification
Open Referral network

Overview

Offers

Face-to-face consultations
Video and telephone consultations

About me

I am a Consultant in Medical Oncology since 2010, specialised in gastrointestinal malignancies since 2013. My main interest is clinical and translational research. Amongst others, I have been awarded the ESMO Translational Research Fellowship in 2010 which led to PhD degree.

I have been a member of various national and international committees, and currently I am the chair of ESMO OncologyPro working Group and member of ESMO GI Faculty group. I was proud to lead the Feasibility study on cancer registration in Greece through the EUROCHIP-2 program and a core member of the PanHellenic Association for Continual Medical Research

Areas of interest

colorectal cancer; chemotherapy; oncology

Medical secretaries

Beverley Timmins (Mrs)
beverly.timmons@nhs.net

About me

Current NHS consultant posts held

Consultant Medical Oncologist at The Christie NHS Foundation Trust.

Research interests

Tumour microenvironment; Prognostic Biomarkers; Chemotherapy Toxicity; Patient Derived Xenografts.
Patient well-being

Personal interests

Music; Sports; Travelling; History

Awards received

- European Society Medical Oncology Translational Research Fellowship (2010)
- Hellenic Society Medical Oncology Fellowship (2010)
- Translational Research Fellowship from Hellenic Society of Medical Oncology (2007)

Publications

- The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic.(Clinical Colorectal Cancer 2020)
- Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic. (Lancet Oncol. 2020)
- Patient and family support in the era of fake e-medicine: food for thought from an international consensus panel. (ESMO Open. 2020)
- The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer. (Clin Colorectal Cancer. 2016)
- The prognostic significance of WNT pathway in surgically-treated colorectal cancer: Î²-catenin expression predicts for disease-free survival. Anticancer Res. 2013

My qualifications & training

Qualifications

Fellow of Royal College of Physicians Royal College of Physicians 2018
Philosopher Doctor (PhD) University Hospital of Larisa, Greece 2018
Specialisation in Medical Oncology Preferectural Self-Government of Athens-Piraeus, Hellenic Republic 2010
Doctor of General Medicine Albert Szent Gyorgi Medical University, Szeged, Hungary 2001

GMC registration

Reference number 6060828

Professional bodies (positions held - last 3 yrs)

Resilience Task Force European Society of Medical Oncology 2020
Chair of Oncology Pro Working Group European Society of Medical Oncology 2021

Details of entry to specialist register

GMC , 2012

My private practice

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)

Spire Leeds Hospital (5-50)
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)

Spire Leeds Hospital (1-5)

Report this page

Finder

Note: